PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages

B CariouC Le MayP CostetClinical aspects of PCSK9Atherosclerosis216258265201110.1016/j.atherosclerosis.2011.04.01821596380

KN MaxwellRE SoccioEM DuncanE SehayekJL BreslowNovel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed miceJ Lipid Res4421092119200310.1194/jlr.M300203-JLR20012897189

NG SeidahS BenjannetL WickhamThe secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiationProc Natl Acad Sci USA100928933200310.1073/pnas.0335507100

T YamamotoC LuRO RyanA two-step binding model of PCSK9 interaction with the low density lipoprotein receptorJ Biol Chem28654645470201110.1074/jbc.M110.19904221149300

J DavignonG DubucNG SeidahThe influence of PCSK9 polymorphisms on serum low-density lipoprotein cholesterol and risk of atherosclerosisCurr Atheroscler Rep12308315201010.1007/s11883-010-0123-620623344

SA MousaviKE BergeTP LerenThe unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasisJ Intern Med266507519200910.1111/j.1365-2796.2009.02167.x19930098

AJ MarianPCSK9 as a therapeutic target in atherosclerosisCurr Atheroscler Rep12151154201010.1007/s11883-010-0099-220425252

CJ DuffNM HooperPCSK9: an emerging target for treatment of hypercholesterolemiaExpert Opin Ther Targets15157168201110.1517/14728222.2011.54748021204732

S PoirierA PratE MarcinkiewiczImplication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous systemJ Neurochem98838850200610.1111/j.1471-4159.2006.03928.x16893422

KR FeingoldAH MoserJK ShigenagaSM PatzekC GrunfeldInflammation stimulates the expression of PCSK9Biochem Biophys Res Commun374341344200810.1016/j.bbrc.2008.07.02318638454

H LanL PangMM SmithProprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cellsJ Cell Physiol224273281201020333646

R RossAtherosclerosis is an inflammatory diseaseAm Heart J138S419S420199910.1016/S0002-8703(99)70266-810539839

G RodriguezN MagoF RosaRole of inflammation in atherogenesisInvest Clin501091292009

P SahaB ModaraiJ HumphriesK MattockM WalthamKG BurnandA SmithThe monocyte/macrophage as a therapeutic target in atherosclerosisCurr Opin Pharmacol9109118200910.1016/j.coph.2008.12.01719230773

CY WuZH TangL JiangXF LiZS JiangLS LiuPCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathwayMol Cell Biochem359347358201210.1007/s11010-011-1028-621847580

ZH TangLS LiuJ PengQ YangHT LiuZS JiangInvestigation of NARC-1 protein expression in atherosclerotic lesion of New Zealand rabbitChin J Arterioscler1735372009(in Chinese)

P LibbyY OkamotoVZ RochaE FolcoInflammation in atherosclerosis: transition from theory to practiceCirc J74213220201020065609

K YinC TangInflammation, lipid metabolism dysfunction, and hypertension: Active research fields in atherosclerosis-related cardiovascular disease in ChinaSci China Life Sci54976979201110.1007/s11427-011-4225-3

KL MaXZ RuanSH PowisY ChenJF MoorheadZ VargheseInflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout miceHepatology48770781200810.1002/hep.2242318752326

K YinDF LiaoCK TangATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transportMol Med16438449201020485864

K YinX DengZC MoTristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A–I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3J Biol Chem2861383413845201121339300

A RoubtsovaMN MunkondaZ AwanCirculating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissueArterioscler Thromb Vasc Biol31785791201110.1161/ATVBAHA.110.220988

OL HollaJ CameronK TvetenTB StromKE BergeJK LaerdahlTP LerenRole of the C-terminal domain of PCSK9 in degradation of the LDL receptorsJ Lipid Res5217871794201110.1194/jlr.M01809321771976

AK SoutarUnexpected roles for PCSK9 in lipid metabolismCurr Opin Lipidol22192196201110.1097/MOL.0b013e32834622b521494143

TS FisherP Lo SurdoS PanditEffects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulationJ Biol Chem2822050220512200710.1074/jbc.M70163420017493938

D CunninghamDE DanleyKF GeogheganStructural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemiaNat Struct Mol Biol14413419200710.1038/nsmb123517435765

DW ZhangTA LagaceR GarutiZ ZhaoM McDonaldJD HortonJC CohenHH HobbsBinding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradationJ Biol Chem2821860218612200710.1074/jbc.M702027200

J CameronOL HollaT RanheimMA KulsethKE BergeTP LerenEffect of mutations in the PCSK9 gene on the cell surface LDL receptorsHum Mol Genet1515511558200610.1093/hmg/ddl07716571601

M MbikayF SiroisJ MaynePCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalitiesFEBS Lett584701706201010.1016/j.febslet.2009.12.01820026049

C LanghiC Le MayV GmyrPCSK9 is expressed in pancreatic delta-cells and does not alter insulin secretionBiochem Biophys Res Commun39012881293200910.1016/j.bbrc.2009.10.13819878649

K De BosscherBW VandenG HaegemanThe interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repressionEndocr Rev244885222003

G GloireS Legrand-PoelsJ PietteNF-kappaB activation by reactive oxygen species: fifteen years laterBiochem Pharmacol7214931505200616723122

MP de WintherE KantersG KraalMH HofkerNuclear factor kappaB signaling in atherogenesisArterioscler Thromb Vasc Biol25904914200515731497

C XieJ KangME FergusonS NagarajanTM BadgerX WuBlueberries reduce pro-inflammatory cytokine TNF-α and IL-6 production in mouse macrophages by inhibiting NF-κB activation and the MAPK pathwayMol Nutr Food Res55158715912011

L LeiH LiF YanY LiY XiaoPorphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cellsJ Periodontal Res46427437201110.1111/j.1600-0765.2011.01356.x